AstraZeneca shares fall on report of potential China probe fallout
AstraZeneca shares recorded their biggest one-day drop since March 2020 on Tuesday following a report that dozens of senior executives at its China unit could be implicated in the largest insurance fraud case in the country's pharma sector in years.
(Yicai) Nov. 6 -- Major multinational automakers, including Volkswagen Group, Ford Motor, and Stellantis, reported disappointing sales in China in the quarter ended September as the country’s rapidly ...
AstraZeneca's shares have fallen more than 8% on speculation about an anti-corruption probe in China, its second-largest ...
AstraZeneca’s stock price dropped by 8.4% during Tuesday’s trading in London after a report fueled fears of a potentially ...
Seeking Alpha on MSN17h
AstraZeneca falls as fraud investigation reportedly expands in China (update)An insurance fraud investigation linked to AstraZeneca (AZN) expands in China involving dozens of senior executives. Read ...
AstraZeneca said on Tuesday that it does not comment on speculative media reports, in response to a sharp drop in its share ...
AstraZeneca suffered a £14bn share price hit on Tuesday after Chinese media reported more details about an investigation into ...
This month’s fast rebound was partly the result of very low sales in September, the sales director at one real estate project ...
The decision comes after media reports said it had indefinitely suspended plans to build two battery plants in Germany. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback